Hyaluronic acid dermal fillers: can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration?

Lynnelle Smith, Kimberly Cockerham, Lynnelle Smith, Kimberly Cockerham

Abstract

Hyaluronic acid (HA) dermal fillers are the most widely used injectables to augment facial volume without surgery. HA dermal fillers are popular because of their ease of administration, predictable effectiveness, good safety profile, and quick patient recovery. The most common patient complaint is pain. Our goal is to review the current literature on HA fillers and compare outcomes with and without lidocaine. We found adjunctive lidocaine significantly decreases pain during injection and postinjection with corresponding increased patient satisfaction. The efficacy and safety profile appears unchanged. Rare complications with HA fillers and those associated with constituents of the product, contaminants, and lidocaine are reviewed. The corrective effects of HA fillers are temporary; repeat treatment is required to maintain results. Minimizing pain is crucial to optimize patient satisfaction.

Keywords: collagen; drug toxicity; herpes simplex; hyaluronic acid; hypersensitivity; lidocaine.

References

    1. Levy PM, de Boulle K, Raspaldo H. A split-face comparison of a new hyaluronic acid facial filler containing pre-incorporated lidocaine versus a standard hyaluronic acid facial filler in the treatment of naso-labial folds. J Cosmet Laser Ther. 2009;11(3):169–173.
    1. Beasley KL, Weiss MA, Weiss RA. Soft tissue augmentation using a two-way connector to supplement hyaluronic acid filler with 1% lidocaine hydrochloric acid with epinephrine 1:100,000: our experience and observations. Dermatol Surg. 2010;36(4):524–526.
    1. Levy PM, de Boulle K, Raspaldo H. Comparison of injection comfort of a new category of cohesive hyaluronic acid filler with preincorporated lidocaine and a hyaluronic acid filler alone. Dermatol Surg. 2009;35(Suppl 1):332–336. discussion 337.
    1. Monheit GD, Campbell RM, Neugent H, et al. Reduced pain with use of proprietary hyaluronic acid with lidocaine for correction of nasolabial folds: a patient-blinded, prospective, randomized controlled trial. Dermatol Surg. 2010;36(1):94–101.
    1. Research B. Cosmetic surgery markets: products and services. Last updated 2008. Available from: . Accessed October 8, 2010.
    1. McCracken MS, Khan JA, Wulc AE, et al. Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthal Plast Reconstr Surg. 2006;22(3):188–191.
    1. Rohrich RJ, Herbig KS. Minimizing pain, maximizing comfort: a new technique for facial filler injections. Plast Reconstr Surg. 2009;124(4):1328–1329.
    1. Weinkle SH, Bank DE, Boyd CM, Gold MH, Thomas JA, Murphy DK. A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juvéderm injectable gel with and without lidocaine. J Cosmet Dermatol. 2009;8(3):205–210.
    1. Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging. 2008;3(1):153–159.
    1. Custis T, Beynet D, Carranza D, Greco J, Lask GP, Kim J. Comparison of treatment of melomental fold rhytides with cross-linked hyaluronic acid combined with onabotulinumtoxina and cross-linked hyaluronic acid alone. Dermatol Surg. 2010;36(Suppl 3):1852–1858.
    1. Carruthers J, Carruthers A. A prospective randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg. 2003;29(8):802–809.
    1. Baumann L. Dermal fillers. J Cosmet Dermatol. 2004;3(4):249–250.
    1. Van Dyke S, Hays GP, Caglia AE, Caglia M. Severe acute local reactions to a hyaluronic acid-derived dermal filler. J Clin Aesthet Dermatol. 2010;3(5):32–35.
    1. Alijotas-Reig J, Garcia-Gimenez V. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature. J Eur Acad Dermatol Venereol. 2008;22(2):150–161.
    1. Pinsky MA, Thomas JA, Murphy DK, Walker PS, Juvéderm vs Zyplast Nasolabial Fold Study Group Juvéderm injectable gel: a multicenter, double-blind, randomized study of safety and effectiveness. Aesthet Surg J. 2008;28(1):17–23.
    1. Librowski T, Pytka K, Szaleniec M. Antihistaminic activity of carane derivatives in isolated guinea pig ileum. Pharmacol Rep. 2009;61(6):1211–1215.
    1. Lupo MP, Swetman G, Waller W. The effect of lidocaine when mixed with large gel particle hyaluronic acid filler tolerability and longevity: a six-month trial. J Drugs Dermatol. 2010;9(9):1097–1100.
    1. Wahl G. European evaluation of a new hyaluronic acid filler incorporating lidocaine. J Cosmet Dermatol. 2008;7(4):298–303.
    1. Grimes PE, Thomas JA, Murphy DK. Safety and effectiveness of hyaluronic acid fillers in skin of color. J Cosmet Dermatol. 2009;8(3):162–168.
    1. Bachmann F, Erdmann R, Hartmann V, Wiest L, Rzany B. The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study. Dermatol Surg. 2009;35(Suppl 2):1629–1634.
    1. Narins RS, Jewell M, Rubin M, Cohen JL, Strobos J. Clinical conference: management of rare events following dermal fillers – focal necrosis and angry red bumps. Dermatol Surg. 2006;32(3):426–434.
    1. Kohase H, Umino M. Allergic reaction to epinephrine preparation in 2% lidocaine: two case reports. Anesth Prog. 2004;51(4):134–137.
    1. Mackley CL, Marks JG, Jr, Anderson BE. Delayed-type hypersensitivity to lidocaine. Arch Dermatol. 2003;139(3):343–346.
    1. Andre P, Lowe NJ, Parc A, Clerici TH, Zimmermann U. Adverse reactions to dermal fillers: a review of European experiences. J Cosmet Laser Ther. 2005;7(3–4):171–176.
    1. Cohen JL. Understanding avoiding, and managing dermal filler complications. Dermatol Surg. 2008;34(Suppl 1):S92–S99.
    1. Cockerham K, Hsu VJ. Collagen-based dermal fillers: past, present, future. Facial Plast Surg. 2009;25(2):106–113.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit